Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5088946012 | Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens (medicinal product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 5088947015 | Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens only vaccine product | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 5088948013 | Haemophilus influenzae type b and meningitis C vaccine | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 5580061000005114 | vaccine der kun indeholder antigen fra Haemophilus influenzae type B og Neisseria meningitidis serogruppe C | da | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | Danish module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens (medicinal product) | Is a | Vaccine product containing Neisseria meningitidis antigen (medicinal product) | true | Inferred relationship | Some | ||
| Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens (medicinal product) | Is a | Vaccine product containing Haemophilus influenzae type b antigen (medicinal product) | true | Inferred relationship | Some | ||
| Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens (medicinal product) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Haemophilus influenzae type b antigen | true | Inferred relationship | Some | 1 | |
| Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens (medicinal product) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Neisseria meningitidis serogroup C antigen | true | Inferred relationship | Some | 2 | |
| Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens (medicinal product) | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
| Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens (medicinal product) | Count of base of active ingredient | to | false | Inferred relationship | Some | ||
| Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens (medicinal product) | Count of active ingredient | to | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Administration of Haemophilus influenzae type b and meningitis C vaccine | Direct substance | True | Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens (medicinal product) | Inferred relationship | Some | 1 |
| Administration of second dose of vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens (procedure) | Direct substance | True | Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens (medicinal product) | Inferred relationship | Some | 1 |
| Administration of first dose of Haemophilus influenzae type b and meningitis C vaccine | Direct substance | True | Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens (medicinal product) | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR